Date | Analyst | Company | Last | Target | Call | Valuation |
09/13/21 | DBS Vickers | Econ Healthcare | 0.3 | 0.4 | Buy | DCF |
Subscribe to:
Post Comments (Atom)
New Launch - Rare Freehold Industrial Project For Sale!
Please click the advertisement to whatsapp the sales team.
One Sophia For Sale!
Please click for more details.
Special offer for CT Foodnex! Grab it before it ends!
Click for more details.
Featured Post
NATO and the US are the axis of calumnies!
NATO tried to shift and pin its reprehensive act on China when the fundamental cause of the war was orchestrated by the US. We had stated pr...
Popular Posts
-
Date Analyst Company Last Target Call Valuation 06/19/23 OCBC Keppel Infrastructure 0.49 0.605 Buy 07/27/23 DBS Vickers Keppel Infrastructur...
-
Date Analyst Company Last Target Call Valuation 11/20/23 phillip Vertex Tech 4.95 0 Fully Redeemed
-
Date Analyst Company Last Target Call Valuation 09/25/23 Amfrasers Banyan Tree 0.4 0.415 Buy 04/04/24 Amfrasers Banyan Tree 0.385 0.41 Buy
-
Date Analyst Company Last Target Call Valuation 06/08/23 Kim Eng Top Glove 0.315 0.17 Sell Ringgit target $0.57 06/08/23 Citi Research Top G...
-
Date Analyst Company Last Target Call Valuation 07/18/23 Lim & Tan Tianjin Zhongxin 2.07 0 Hold
-
Date Analyst Company Last Target Call Valuation 10/05/23 Lim & Tan Tiong Woon 0.48 0 Accumulate 10/25/23 Lim & Tan Tiong Woon 0.505 ...
-
Date Analyst Company Last Target Call Valuation 09/04/24 CIMB Capitaland Integrated Commercial Trust 2.13 2.21 Add DDM 09/04/24 DMG & Pa...
-
Date Analyst Company Last Target Call Valuation 05/04/23 UOB Kay Hian Emperador 0.5 0.57 Hold PER31.5x FY23 08/25/23 UOB Kay Hian Emperador ...
-
We've taken cognizant of the current political phenomena in Singapore that show LKY's legacies (political ideologies) are being slow... -
Date Analyst Company Last Target Call Valuation 05/31/23 Amfrasers Fortress Minerals 0.34 0.46 outperform DCF & EV/Resource3.6x 07/20/23...
Received Top 75 Singapore Investment Blogs Award in July 2017
Top 50 Singapore Investment Blogs
No comments:
Post a Comment